» Articles » PMID: 36751544

Current Practices in Diagnosis of Hymenoptera Venom Allergy in Poland

Overview
Publisher Termedia
Date 2023 Feb 8
PMID 36751544
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Hymenoptera venom allergy (HVA) is associated with a high risk of anaphylaxis. Effective treatment of HVA patients requires allergologists' familiarity with the latest HVA recommendations.

Aim: Evaluation of current practices in HVA diagnosis in Poland.

Material And Methods: A survey questionnaire was conducted in 32 HVA centres in Poland.

Results: The response rate was 97%. There were 1829 patients evaluated due to HVA in 2015. Sixty six percent ( = 21) of the centres used skin prick tests, out which 90% ( = 19) used 100 µg/ml of the venom extract as the highest concentration. All the centres performed intradermal tests (IDT) and serum specific IgE (sIgE), an initial diagnostic tool in 91% ( = 29). The highest venom concentration in IDT was 1 µg/ml in 75% ( = 24), 0.1 µg/ml in 16% ( = 5), 0.01 µg/ml in 3% ( = 1) and 10 µg/ml in 6% ( = 2). Baseline serum tryptase was assessed in 84% of the centres ( = 27), out of which 53% ( = 17) tested all their patients, whereas 31% ( = 10) checked only those with life-threatening reactions. In case of negative IDT/sIgE, 59% of the centres ( = 19) performed components evaluation, while 19% ( = 6) did the basophil activation test. In case of no identification of the culprit insect and sensitization to both venoms, VIT employed venom with higher sIgE.

Conclusions: Most allergology centres in Poland follow HVA guidelines. We identified two inaccuracies in their HVA management including non-adequate venom concentration in IDT and a false belief in correspondence between sIgE concentration and severity of allergic reactions.

Citing Articles

Skin prick tests are not useful for the qualification for venom immunotherapy in children.

Cichocka-Jarosz E, Brzyski P, Jedynak-Wasowicz U, Mol N, Klasa B, Mazurek-Durlak Z World Allergy Organ J. 2023; 16(5):100775.

PMID: 37351272 PMC: 10282561. DOI: 10.1016/j.waojou.2023.100775.

References
1.
Bonadonna P, Scaffidi L . Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder. Immunol Allergy Clin North Am. 2018; 38(3):455-468. DOI: 10.1016/j.iac.2018.04.010. View

2.
Grabenhenrich L, Dolle S, Moneret-Vautrin A, Kohli A, Lange L, Spindler T . Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. J Allergy Clin Immunol. 2016; 137(4):1128-1137.e1. DOI: 10.1016/j.jaci.2015.11.015. View

3.
Swender D, Chernin L, Mitchell C, Sher T, Hostoffer R, Tcheurekdjian H . The rate of epinephrine administration associated with allergy skin testing in a suburban allergy practice from 1997 to 2010. Allergy Rhinol (Providence). 2013; 3(2):e55-60. PMC: 3548609. DOI: 10.2500/ar.2012.3.0034. View

4.
Diwakar L, Ewan P, Huber P, Clark A, Nasser S, Krishna M . The impact of national guidelines on venom immunotherapy practice in the United Kingdom. Clin Exp Allergy. 2016; 46(5):749-53. PMC: 4869676. DOI: 10.1111/cea.12728. View

5.
Cichocka-Jarosz E, Stobiecki M, Nittner-Marszalska M, Jedynak-Wasowicz U, Brzyski P . Venom allergy treatment practices in Poland in comparison to guidelines: next edition of the national audit. Postepy Dermatol Alergol. 2019; 36(3):346-353. PMC: 6640023. DOI: 10.5114/ada.2019.85642. View